Evaluation of Pediatric HIV Postexposure Prophylaxis Guideline Following Child Sexual Assault in Western Australia

Momoko Combs1, Alice Johnson2, Joanne Abbotsford3

  • 1From the Department of Infectious Diseases, Perth Children's Hospital.

Insights

Adherence to HIV postexposure prophylaxis (PEP) after child sexual assault (CSA) is low, with less than half of eligible children completing the regimen. Improvements in PEP management and follow-up are needed.

Area of Science:

  • Pediatric infectious diseases
  • Public health
  • Clinical management of child sexual assault

Background:

  • HIV postexposure prophylaxis (PEP) is recommended for children following child sexual assault (CSA) in specific circumstances.
  • Poor adherence to PEP regimens is a significant concern in this population.
  • Current international guidelines for PEP in pediatric CSA cases lack specificity.

Purpose of the Study:

  • To evaluate adherence to PEP management for children following CSA at a tertiary pediatric facility.
  • To compare the facility's approach with existing international PEP guidelines.
  • To identify areas for improvement in pediatric PEP protocols.

Main Methods:

  • Retrospective review of medical records for children under 16 assessed for CSA at Perth Children's Hospital (October 2016 - November 2020).
  • Data collection included exposure details, PEP prescription, adherence, and follow-up.
  • Parallel review of contemporary national and international PEP guidelines.

Main Results:

  • 511 alleged CSA events were identified; 12% were assessed as requiring PEP.
  • PEP was not prescribed in 13% of eligible cases.
  • Only 43% of eligible children adhered to the 28-day PEP regimen; gastrointestinal upset was a common reason for early cessation.
  • 3-month serology results were available for less than one-third of children.
  • International guidelines showed significant heterogeneity in PEP criteria and limited pediatric-specific data.

Conclusions:

  • Significant improvements are needed in the management of PEP for children following CSA.
  • The facility has adopted broader use of fixed-drug combinations and a comprehensive follow-up program.
  • Ongoing review is essential to assess the impact of implemented changes on PEP adherence and outcomes.
Abstract